Last Updated: November 16, 2026

Investigational Drug Information for Tricaprilin

« Back to Dashboard


What is the drug development status for Tricaprilin?

Tricaprilin is an investigational drug.

There have been 14 clinical trials for Tricaprilin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 30th 2022.

The most common disease conditions in clinical trials are Alzheimer Disease, Spasm, and Migraine Disorders. The leading clinical trial sponsors are Cerecin, Accera, Inc., and [disabled in preview].

There are zero US patents protecting this investigational drug and zero international patents.

Recent Clinical Trials for Tricaprilin
TitleSponsorPhase
Tricaprilin Phase 3 AD StudyCerecinPhase 3
AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing ConditionsCerecinPhase 1
A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy SubjectsCerecinPhase 1

See all Tricaprilin clinical trials

Clinical Trial Summary for Tricaprilin

Top disease conditions for Tricaprilin
Top clinical trial sponsors for Tricaprilin

See all Tricaprilin clinical trials

US Patents for Tricaprilin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tricaprilin ⤷  Start Trial Targeted poorly water-soluble drug delivery system, method of preparing the same, and pharmaceutical composition including the same Samsung Life Public Welfare Foundation ⤷  Start Trial
Tricaprilin ⤷  Start Trial Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse Acura Pharmaceuticals, Inc. (Palatine, IL) ⤷  Start Trial
Tricaprilin ⤷  Start Trial Stapled helical peptides and methods of synthesis University of Hong Kong HKU ⤷  Start Trial
Tricaprilin ⤷  Start Trial Oxidative hair dye composition Hoyu Co Ltd ⤷  Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tricaprilin

Drugname Country Document Number Estimated Expiration Related US Patent
Tricaprilin European Patent Office EP2896401 2032-09-12 ⤷  Start Trial
Tricaprilin South Korea KR101493930 2032-09-12 ⤷  Start Trial
Tricaprilin South Korea KR20140036338 2032-09-12 ⤷  Start Trial
Tricaprilin World Intellectual Property Organization (WIPO) WO2014042450 2032-09-12 ⤷  Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.